Ohio Innovation Fund is a venture capital firm based in Columbus, Ohio, specializing in early-stage and startup investments. Founded in 2016, the firm focuses on the technology sector, with particular interest in medical technology, biopharma, augmented and virtual reality, advanced manufacturing, software as a service, artificial intelligence, machine learning, cybersecurity, and mobility. Ohio Innovation Fund primarily invests in companies located in Ohio, typically providing funding between $250,000 and $500,000, with the potential for up to $1.25 million based on specific milestones achieved by the companies.
Niobium Microsystems specializes in developing custom integrated circuits and microelectronic systems tailored for clients facing complex power, performance, and security challenges. The company focuses on high-performance microelectronic components that facilitate the secure collection, processing, and distribution of critical data. Notably, Niobium Microsystems has designed a complete system-on-chip (SoC) for fully homomorphic encryption (FHE), which enhances data security while providing semiconductor solutions. Through its innovative offerings, the company aims to help clients safeguard their data effectively.
Trace
Pre Seed Round in 2024
Trace is the Canva for AR. The simplest way ever to make AR recordings and experiences for brands, retail, training and more. Partners include teams at Qualcomm, Deutsche Telekom, Lenovo, Telefonica and other fortune 500 companies. Contact us to work together or learn more. Info@Trace3d.app
Clarametyx Biosciences
Series A in 2024
Clarametyx Biosciences, Inc. is a biotechnology company based in Columbus, Ohio, focused on developing targeted and immune-enabling biologic therapies to address persistent infections linked to biofilms. Founded in 2020, the company utilizes a novel technology platform designed to penetrate the protective layers surrounding bacteria, facilitating immune responses and enhancing the effectiveness of antibiotic interventions. Among its key developments is CMTX-001, a humanized monoclonal antibody currently in preclinical stages aimed at treating hospital-acquired pneumonia. Clarametyx's innovative approach seeks to combat life-threatening infections while addressing the growing concerns of antibiotic resistance.
AKRU
Seed Round in 2022
AKRU is a commercial real estate investment platform that utilizes blockchain technology to facilitate fractional ownership of real estate assets. By offering security tokens, the platform allows investors to participate with a minimum investment of $1,000. This innovative approach not only enhances accessibility but also significantly shortens the transaction cycle, enabling instant recording of transactions on an immutable ledger. This feature fosters trust among investors and provides them with greater control and liquidity over their investments. Since its beta launch in October 2020, AKRU has successfully secured 14 assets and attracted over 50 investors. The platform was relaunched in March 2021 as a prominent sponsor for the Security Token Summit, further establishing its presence in the industry. AKRU has garnered attention from various major publications, highlighting its role in modernizing real estate investment.
Enable Injections
Series C in 2022
Enable Injections, LLC specializes in the design and manufacture of disposable, body-worn bolus injectors that facilitate the delivery of high viscosity and volume injectable drugs directly into subcutaneous tissue. Established in 2010 and based in Cincinnati, Ohio, the company’s innovative devices can utilize standard containers such as vials, syringes, or cartridges. These injectors not only allow for the reconstitution of powdered drugs but also enable the delivery of up to 20 ml of medication. The system automatically warms and mixes lyophilized solutions, ensuring a seamless injection experience. Additionally, Enable Injections offers a version of its platform that can connect to smartphones via Bluetooth, enhancing user interaction. With approximately 900 new drugs in development that may benefit from this technology, the market for bolus injection systems is projected to reach $8 billion within the next decade.
Aware
Series C in 2021
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.
DAtAnchor
Convertible Note in 2021
Traditional IT controls focus on locking down networks, devices, and people. All of this is done in the name of protecting data. But, once files are moved, shared, or stolen, the data is no longer protected. Even worse, these controls get in the way and frustrate business users to the point they intentionally work around them. Anchor inverts the equation by baking protection into the data, invisible to the business users (like antivirus), so that files are free to travel and security is out of the way. Simply put, wherever the data goes, it is protected. Anchor is a SaaS platform, with an endpoint component, that bakes protection into your files with a unique transparent combination of encryption, continuous multi-factor access controls, and a digital chain of custody. And when you do share or collaborate, Anchor protection stays with your data, even when it leaves your organization. Anchor empowers you to maintain control of your files while collaborating on premise or in the cloud, including forensic logging and revoking access. In under 90 minutes, Anchor is fully deployed and empowers your business users to securely work and collaborate without complicated security products or rules in the way. All without requiring you to change existing IT controls or how your users and applications work today. DAtAnchor is a result of a multi-year research activity, developed at Ohio State University. The development team currently has 6 members, 4 of which are full-time. We have seed level funding for >1M and an advisory board with members at the senior vice president level in Fortune 500 companies.
S4 Medical
Series A in 2021
S4 Medical Corp. is a medical device company based in Cleveland, Ohio, founded in 2017. The company specializes in developing innovative solutions for catheter ablation treatment, specifically targeting atrial fibrillation. Its primary product, the eSolution device, is designed to minimize complications to the esophagus during ablation procedures. This device allows healthcare providers to protect the esophagus and aids electrophysiologists in determining the necessary adjustments for effective treatment. S4 Medical's focus on enhancing patient safety in cardiac procedures reflects its commitment to improving outcomes in the field of electrophysiology.
eFuse
Venture Round in 2021
eFuse is a digital platform tailored for the esports and video game industry, founded in 2018 and based in Columbus, Ohio. It serves as a central hub for individuals to build their gaming identities and engage with the industry at various levels. The platform offers resources for learning about the gaming landscape, networking with peers, and accessing opportunities such as jobs and scholarships. Additionally, eFuse facilitates collaborations within the gaming community, focusing on player talent recruitment, job placement, and sponsorship sourcing. By providing these services, eFuse aims to enhance the overall experience for gamers and industry professionals alike.
Aware
Series B in 2020
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.
ScriptDrop
Series A in 2020
ScriptDrop’s technology platform enables connectivity across the healthcare ecosystem connecting patients, pharmacists, providers, and pharmaceutical manufacturers. The platform provides a seamless experience for patients, offering them prescription delivery in all 50 states and allowing for important additional services to be provided for better adherence. The company was founded in 2016 and is headquartered in Columbus, Ohio.
Immuta
Series C in 2020
Immuta, Inc. develops a data security platform that helps organizations manage data security, privacy, and access control. The platform offers automated data governance features, including sensitive data discovery, classification, and the ability to author security and access control policies without coding. It enables self-service access to data while providing visibility into data usage. Immuta's solution is utilized by a diverse range of sectors, including finance, healthcare, government, and manufacturing, for purposes such as cloud migration, regulatory compliance, and secure collaboration. Founded in 2015 and headquartered in Boston, Massachusetts, Immuta has established itself as a trusted partner for Fortune 500 companies and government agencies worldwide.
Genetesis
Series B in 2020
Genetesis LLC is a medical technology company based in Mason, Ohio, that specializes in biomagnetic imaging solutions to improve patient diagnosis and monitoring of cardiac conditions. Founded in 2013, the company has developed the Genetesis CardioFlux, a mapping system designed to enhance the detection and treatment of cardiac rhythm disorders by visualizing the heart's electrical currents in three dimensions. Additionally, Genetesis offers the Faraday Analytical Cloud, a HIPAA-compliant platform that manages the data workflow for the CardioFlux magnetocardiograph. The system is non-invasive and avoids exposing patients to radiation or requiring exercise, enabling clinicians to accurately measure the magnetic signals generated by the heart during its electrical activity.
S4 Medical
Venture Round in 2020
S4 Medical Corp. is a medical device company based in Cleveland, Ohio, founded in 2017. The company specializes in developing innovative solutions for catheter ablation treatment, specifically targeting atrial fibrillation. Its primary product, the eSolution device, is designed to minimize complications to the esophagus during ablation procedures. This device allows healthcare providers to protect the esophagus and aids electrophysiologists in determining the necessary adjustments for effective treatment. S4 Medical's focus on enhancing patient safety in cardiac procedures reflects its commitment to improving outcomes in the field of electrophysiology.
Able (formerly EmployStream)
Series B in 2020
EmployStream is a hiring workflow automation software platform for staffing companies and other high-volume employers. It also creates high-quality, user-friendly for high-volume employers that automates the hiring and onboarding process for employers. The platform eliminates costly mistakes and delays allowing companies to hire up to 90% faster and at half the cost. The company provides an online hiring platform which offers different features such as paper onboarding, real-time alerting, online application, background checks, applicant pre & interview screening, and verification. EmployStream was founded in 2014 and is headquartered in Cleveland Ohio, USA.
Windpact
Venture Round in 2019
Windpact, Inc. is a provider of impact protection solutions that cater to various sectors, including sports, military, automotive, construction, and medical applications. Founded in 2011 and based in Leesburg, Virginia, the company offers a platform as a service that enables product development teams to explore innovative foam solutions. Windpact's technology incorporates machine learning, finite element analysis (FEA) modeling, and a unique Crash Cloud system, which dynamically adjusts to various impact rates, ensuring effective protection for individuals at risk of impact. Additionally, Windpact develops software tools that assist product developers throughout the growth stages, featuring capabilities such as an auto-packer for three-dimensional manufacturing and design optimization. These tools aim to enhance design timelines and reduce development costs, enabling designers to achieve optimal performance aligned with their product objectives.
eFuse
Seed Round in 2019
eFuse is a digital platform tailored for the esports and video game industry, founded in 2018 and based in Columbus, Ohio. It serves as a central hub for individuals to build their gaming identities and engage with the industry at various levels. The platform offers resources for learning about the gaming landscape, networking with peers, and accessing opportunities such as jobs and scholarships. Additionally, eFuse facilitates collaborations within the gaming community, focusing on player talent recruitment, job placement, and sponsorship sourcing. By providing these services, eFuse aims to enhance the overall experience for gamers and industry professionals alike.
Able (formerly EmployStream)
Series A in 2019
EmployStream is a hiring workflow automation software platform for staffing companies and other high-volume employers. It also creates high-quality, user-friendly for high-volume employers that automates the hiring and onboarding process for employers. The platform eliminates costly mistakes and delays allowing companies to hire up to 90% faster and at half the cost. The company provides an online hiring platform which offers different features such as paper onboarding, real-time alerting, online application, background checks, applicant pre & interview screening, and verification. EmployStream was founded in 2014 and is headquartered in Cleveland Ohio, USA.
Complion
Series B in 2019
Complion platform offers tremendous benefits to every role in the clinical trial ecosystem. It allows administrators and research coordinators to more efficiently maintain compliance protocols. It unleashes investigators to explore potential innovation with fewer hassles. It streamlines crucial information that auditors and quality assurance personnel need and it permits collaborators and reviewers to more easily participate in clinical research.
Stirling Ultracold
Series B in 2018
Stirling Ultracold, a division of Global Cooling, Inc., is a developer and manufacturer of a new generation of environmentally friendly ultra-low temperature freezers which operate below -86°C. These freezers do not use dry ice, Peltier or conventional cascade refrigeration systems. Instead, the Stirling Ultracold product line operates on free-piston Stirling engine technology.
DAtAnchor
Seed Round in 2018
Traditional IT controls focus on locking down networks, devices, and people. All of this is done in the name of protecting data. But, once files are moved, shared, or stolen, the data is no longer protected. Even worse, these controls get in the way and frustrate business users to the point they intentionally work around them. Anchor inverts the equation by baking protection into the data, invisible to the business users (like antivirus), so that files are free to travel and security is out of the way. Simply put, wherever the data goes, it is protected. Anchor is a SaaS platform, with an endpoint component, that bakes protection into your files with a unique transparent combination of encryption, continuous multi-factor access controls, and a digital chain of custody. And when you do share or collaborate, Anchor protection stays with your data, even when it leaves your organization. Anchor empowers you to maintain control of your files while collaborating on premise or in the cloud, including forensic logging and revoking access. In under 90 minutes, Anchor is fully deployed and empowers your business users to securely work and collaborate without complicated security products or rules in the way. All without requiring you to change existing IT controls or how your users and applications work today. DAtAnchor is a result of a multi-year research activity, developed at Ohio State University. The development team currently has 6 members, 4 of which are full-time. We have seed level funding for >1M and an advisory board with members at the senior vice president level in Fortune 500 companies.
Enable Injections
Series B in 2018
Enable Injections, LLC specializes in the design and manufacture of disposable, body-worn bolus injectors that facilitate the delivery of high viscosity and volume injectable drugs directly into subcutaneous tissue. Established in 2010 and based in Cincinnati, Ohio, the company’s innovative devices can utilize standard containers such as vials, syringes, or cartridges. These injectors not only allow for the reconstitution of powdered drugs but also enable the delivery of up to 20 ml of medication. The system automatically warms and mixes lyophilized solutions, ensuring a seamless injection experience. Additionally, Enable Injections offers a version of its platform that can connect to smartphones via Bluetooth, enhancing user interaction. With approximately 900 new drugs in development that may benefit from this technology, the market for bolus injection systems is projected to reach $8 billion within the next decade.
Alviere
Series A in 2018
Alviere is a finance platform that offers embedded financial products and technology, allowing businesses to deliver a range of financial services to their customers. The platform facilitates banking, mobile payments, card issuance, payment processing, and cross-border currency exchange. By providing a flexible framework, Alviere enables brands to launch new financial service lines, thereby enhancing customer relationships and insights while boosting satisfaction and retention. This approach not only strengthens customer connections but also helps businesses increase revenue and maximize profits.
RXQ Compounding
Series A in 2018
RXQ Compounding, LLC is an FDA-approved 503B Outsourcing Facility located in Athens, Ohio, specializing in the manufacture and distribution of sterile and non-sterile medications throughout the United States. Founded in 2014, the company offers a diverse range of products including sterile and non-sterile injectables, veterinary medications, dermatologic creams and ointments, ophthalmic solutions, and orthopedic steroids, along with custom production solutions for hospitals. RXQ Compounding emphasizes safety and quality by adhering to rigorous regulatory standards and has developed a proprietary procedural manual to ensure compliance with FDA guidelines. The company's commitment to delivering reliable compounded drugs enables healthcare providers to access quality medications efficiently, ultimately supporting optimal patient outcomes.
Eccrine Systems
Series B in 2018
Eccrine Systems is developing non-invasive, electronic wearable systems that measure and transmit real-time data about human sweat. The ability to monitor sweat biomarkers with chronological accuracy is the key to attaining market-enabling improvements in the predictive value of non-invasive wearables data - across a wide spectrum of applications for medicine, industry, and sport. Eccrine Systems collaborates with capable downstream partners who have deep understanding of vertical application opportunities, enabling the translation of our foundational technology and IP portfolio into market leading products and solutions.
Mezu
Venture Round in 2018
Mezu, Inc., established in 2017 and based in Cleveland Heights, Ohio, operates in the banking industry with a focus on mobile payments. The company offers a secure and private mobile payment app that allows users to send and receive money without revealing personal information. This platform enables users to pay, tip, earn, and donate easily and at no cost, prioritizing user privacy and discretion in financial transactions. Mezu's app is accessible on both iOS and Android devices in the United States, reflecting its commitment to providing a cash-like experience in digital payments.
Genetesis
Series A in 2018
Genetesis LLC is a medical technology company based in Mason, Ohio, that specializes in biomagnetic imaging solutions to improve patient diagnosis and monitoring of cardiac conditions. Founded in 2013, the company has developed the Genetesis CardioFlux, a mapping system designed to enhance the detection and treatment of cardiac rhythm disorders by visualizing the heart's electrical currents in three dimensions. Additionally, Genetesis offers the Faraday Analytical Cloud, a HIPAA-compliant platform that manages the data workflow for the CardioFlux magnetocardiograph. The system is non-invasive and avoids exposing patients to radiation or requiring exercise, enabling clinicians to accurately measure the magnetic signals generated by the heart during its electrical activity.
Immuta
Series B in 2018
Immuta, Inc. develops a data security platform that helps organizations manage data security, privacy, and access control. The platform offers automated data governance features, including sensitive data discovery, classification, and the ability to author security and access control policies without coding. It enables self-service access to data while providing visibility into data usage. Immuta's solution is utilized by a diverse range of sectors, including finance, healthcare, government, and manufacturing, for purposes such as cloud migration, regulatory compliance, and secure collaboration. Founded in 2015 and headquartered in Boston, Massachusetts, Immuta has established itself as a trusted partner for Fortune 500 companies and government agencies worldwide.
ConnXus
Series A in 2018
ConnXus, Inc. is a provider of online services that connect diverse and small businesses with larger companies looking to enhance their supplier diversity. The company specializes in aggregating corporate purchasing demand, helping organizations locate, evaluate, and engage small, minority- or woman-owned businesses across various sectors, including construction, transportation, and information technology. ConnXus offers tools such as ConnXus Scrub, a data enrichment solution for validating supplier classifications, and TierTracker, a platform for reporting and management. Additionally, it features a diverse supplier search platform and a community marketplace that fosters networking and the sharing of best practices among supplier diversity professionals. ConnXus also assists registered suppliers in marketing their services and maintaining their certifications. Incorporated in 2010 and headquartered in Mason, Ohio, with a satellite office in Portland, Oregon, ConnXus serves Fortune 2000 and Fortune 500 companies and operates as a subsidiary of Coupa Software Incorporated.
Aware
Series A in 2018
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.
Immuta
Series A in 2017
Immuta, Inc. develops a data security platform that helps organizations manage data security, privacy, and access control. The platform offers automated data governance features, including sensitive data discovery, classification, and the ability to author security and access control policies without coding. It enables self-service access to data while providing visibility into data usage. Immuta's solution is utilized by a diverse range of sectors, including finance, healthcare, government, and manufacturing, for purposes such as cloud migration, regulatory compliance, and secure collaboration. Founded in 2015 and headquartered in Boston, Massachusetts, Immuta has established itself as a trusted partner for Fortune 500 companies and government agencies worldwide.
Aware
Series A in 2017
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.
Aware
Series A in 2017
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.
Enable Injections
Series A in 2016
Enable Injections, LLC specializes in the design and manufacture of disposable, body-worn bolus injectors that facilitate the delivery of high viscosity and volume injectable drugs directly into subcutaneous tissue. Established in 2010 and based in Cincinnati, Ohio, the company’s innovative devices can utilize standard containers such as vials, syringes, or cartridges. These injectors not only allow for the reconstitution of powdered drugs but also enable the delivery of up to 20 ml of medication. The system automatically warms and mixes lyophilized solutions, ensuring a seamless injection experience. Additionally, Enable Injections offers a version of its platform that can connect to smartphones via Bluetooth, enhancing user interaction. With approximately 900 new drugs in development that may benefit from this technology, the market for bolus injection systems is projected to reach $8 billion within the next decade.
Spirosure
Series C in 2016
Spirosure develops and manufactures breath-analysis devices aimed at improving disease diagnosis and management through non-invasive technology. The company focuses on chronic respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and chronic pulmonary hypertension. By utilizing advanced sensors and algorithms, Spirosure's devices enable the detection of biomarkers in patients' breath, which assists medical researchers in diagnosing and monitoring these conditions. Additionally, the technology supports the monitoring of medication adherence for asthma patients, contributing to better management of chronic diseases and enhancing preventative healthcare.
DOmedia
Series A in 2016
DOmedia, LLC is an independent technology company based in Columbus, Ohio, that operates a media buying and selling platform focused on out-of-home media. Founded in 2007, the company provides cloud-based applications that facilitate the management of media information, proposal requests, and vendor interactions. Its online marketplace allows media providers to create profiles for their properties, while advertisers and agencies can access a comprehensive database to discover new ideas and efficiently plan out-of-home campaigns. By connecting buyers and sellers, DOmedia aims to streamline processes, reduce labor, and enhance reporting and analytics for agencies, vendors, and brands globally.
DecisionDesk
Debt Financing in 2013
DecisionDesk Inc. offers a comprehensive application and enrollment management solution designed to streamline digital admissions processes for higher education institutions, fine arts programs, and non-profits. Founded in 2008 and based in Lakewood, Ohio, the company provides a suite of technology tools that enhance application management, including hosted applications, student dashboards, communication tools, and mobile review capabilities. Its end-to-end admissions solution encompasses intuitive tools for applicants and staff, facilitating the processing of applications across multiple campuses with real-time customer relationship management (CRM) integration. DecisionDesk simplifies complex evaluation processes by accommodating various application types, such as portfolios and video submissions, ensuring rapid and integrated review. The platform is designed to integrate seamlessly with existing systems, enhancing the efficiency of admission workflows and saving institutions time and resources.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.